Sarat Chandarlapaty's guest appearances

Sarat Chandarlapaty

Investigating Breast Cancer

Karen Anderson

Robert Schneider

Walter Willett

Michael Clarke

Mark Robson

Mina Bissell

Lawrence Shulman

Larry Norton

Jack Cuzick

Luca Gianni

Alan Ashworth

Lori Pierce

Hedvig Hricak

Ann Partridge

Priscilla Brastianos

OwlTail

Advances in cancer therapy have dramatically contributed to the decline in breast cancer deaths over the last three decades. But even with these advances, drug resistance—when tumors stop responding to anti-cancer drugs—remains a serious clinical challenge. Dr. Sarat Chandarlapaty talks about the strategies to prevent cancer cells from evading the drugs designed to kill them.  Dr. Chandarlapaty is a laboratory head at the Human Oncology and Pathogenesis Program at the Memorial Sloan Kettering Cancer Center. He's also a BCRF Scientific Advisory Board member and has been a BCRF researcher since 2015.

<p>Advances in cancer therapy have dramatically contributed to the decline in breast cancer deaths over the last three decades. But even with these advances, drug resistance—when tumors stop responding to anti-cancer drugs—remains a serious clinical challenge. Dr. Sarat Chandarlapaty talks about the strategies to prevent cancer cells from evading the drugs designed to kill them. </p> <p>Dr. Chandarlapaty is a laboratory head at the Human Oncology and Pathogenesis Program at the Memorial Sloan Kettering Cancer Center. He's also a BCRF Scientific Advisory Board member and has been a BCRF researcher since 2015.</p>

The Underlying Biology of Drug Resistance with Dr. Sarat Chandarlapaty